PHBI (Pharmagreen Biotech) Total Equity: $-2.15 Mil (As of Jun. 2023)


What is Pharmagreen Biotech Total Equity?

Pharmagreen Biotech PHBI Total Equity is $-2.15 Mil as of Jun. 2023.

Pharmagreen Biotech's total equity for the quarter that ended in Jun. 2023 was $-2.15 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Pharmagreen Biotech Total Equity Historical Data

* Premium members only.

The historical data trend for Pharmagreen Biotech's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagreen Biotech Total Equity Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
Total Equity
Get a 7-Day Free Trial -1.39 -0.83 -2.93 -1.69 -1.82

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.94 -1.82 -1.80 -1.99 -2.15

Pharmagreen Biotech Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Pharmagreen Biotech's Total Equity for the fiscal year that ended in Sep. 2022 is calculated as

Total Equity=Total Assets(Q: Sep. 2022 )-Total Liabilities(Q: Sep. 2022 )
=0.209-2.032
=-1.82

Pharmagreen Biotech's Total Equity for the quarter that ended in Jun. 2023 is calculated as

Total Equity=Total Assets(Q: Jun. 2023 )-Total Liabilities(Q: Jun. 2023 )
=0.14-2.291
=-2.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-2.15 Mil mean?
Pharmagreen Biotech (PHBI) has a Total Equity of $-2.15 Mil as of Jun. 2023. The total amount of equity as record on a company's balance sheet. View historical data for Pharmagreen Biotech and its competitors.
Is Pharmagreen Biotech's Total Equity too high?
Pharmagreen Biotech's current Total Equity is $-2.15 Mil.
How does Pharmagreen Biotech's Total Equity compare to DVLP and CSTF?
Pharmagreen Biotech's Total Equity of $-2.15 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Pharmagreen Biotech and its competitors. Pharmagreen Biotech's current Total Equity is $-2.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagreen Biotech stock overvalued right now?
Pharmagreen Biotech (PHBI) has a current Total Equity of $-2.15 Mil. The current Total Equity is $-2.15 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Pharmagreen Biotech (PHBI), the current Total Equity is $-2.15 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagreen Biotech Business Description

Address 112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.